April 3, 2008 - Entelos, Inc. (LSE:ENTL) a leading life sciences company building predictive computer models of human physiology and "virtual patients" for drug discovery and development, announced today that the U.S. Patent and Trademark Office has granted U.S. Patent No. 7,353,152 entitled "Method and Apparatus for Computer Modeling Diabetes" to the Company. This enabling technology forms the basis for the Entelos® Metabolism PhysioLab® platform, an innovative and predictive computer model that can simulate diabetic patients and drug effects and is used to select the most effective compounds, find the best doses, and support clinical trial design... Entelos' Press Release -
Monday, April 14, 2008
Entelos : U.S. Patent for its Diabetes Model
April 3, 2008 - Entelos, Inc. (LSE:ENTL) a leading life sciences company building predictive computer models of human physiology and "virtual patients" for drug discovery and development, announced today that the U.S. Patent and Trademark Office has granted U.S. Patent No. 7,353,152 entitled "Method and Apparatus for Computer Modeling Diabetes" to the Company. This enabling technology forms the basis for the Entelos® Metabolism PhysioLab® platform, an innovative and predictive computer model that can simulate diabetic patients and drug effects and is used to select the most effective compounds, find the best doses, and support clinical trial design... Entelos' Press Release -
